PATH | VRL
Menu

Safety and Immunogenicity of Live-Attenuated Japanese Encephalitis SA 14-14-2 Vaccine Co-Administered With Measles Vaccine in 9-Month-Old Infants in Sri Lanka

This article, published in Vaccine, examines the safety and immunogenicity of live attenuated Japanese encephalitis vaccine (LJEV) when administered with measles vaccine in nine-month-old Sri Lankan infants. The results support the use of LJEV at nine months of age and the safety of co-administration with measles vaccine.

Author: Wijesinghe PR, Abeysinghe MRN, Yoksan S, et al.

Published: 2014

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Wijesinghe PR, Abeysinghe MRN, Yoksan S, et al. Safety and Immunogenicity of Live-Attenuated Japanese Encephalitis SA 14-14-2 Vaccine Co-Administered With Measles Vaccine in 9-Month-Old Infants in Sri Lanka. Vaccine. 2014;Early Online Publication.

Resource types: Peer-reviewed journal

Diseases/vaccines: Japanese encephalitis

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Asia